Gregory Renza
Stock Analyst at Truist Financial
(4.80)
# 537
Out of 5,078 analysts
872
Total ratings
51.2%
Success rate
15.2%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Reiterated: Buy | $240 → $241 | $186.99 | +28.88% | 11 | Oct 19, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $11 | $1.61 | +583.23% | 21 | Oct 13, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $34 → $33 | $25.34 | +30.23% | 28 | Oct 13, 2026 | |
| GMAB Genmab | Reiterated: Buy | $45 | $43.79 | +2.76% | 8 | Oct 8, 2026 | |
| MNKD MannKind | Reiterated: Buy | $6 → $5 | $3.19 | +56.74% | 41 | Oct 8, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $420 | $377.63 | +11.22% | 19 | Oct 8, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Buy | $37 | $37.00 | - | 46 | Oct 7, 2026 | |
| AMGN Amgen | Reiterated: Hold | $380 | $439.26 | -13.49% | 44 | Oct 7, 2026 | |
| EXEL Exelixis | Reiterated: Hold | $54 | $64.53 | -16.32% | 37 | Oct 7, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $158 | $156.04 | +1.26% | 18 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $286 | $214.00 | +33.64% | 45 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $772 → $780 | $805.02 | -3.11% | 15 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $85 | $24.40 | +248.36% | 4 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $28.22 | +20.48% | 8 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $25.18 | +15.17% | 35 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $155 → $151 | $88.01 | +71.57% | 13 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.57 | - | 29 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $61.71 | - | 23 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.71 | - | 34 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.37 | - | 37 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.44 | - | 5 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.68 | - | 18 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.55 | +97.18% | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $19.73 | n/a | 57 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.44 | n/a | 24 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $0.8971 | n/a | 36 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $3.53 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $10.04 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $46 | $0.51 | n/a | 8 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $36.42 | n/a | 31 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $0.1651 | n/a | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $13 | $7.85 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $38 | $45.15 | n/a | 26 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2,160 → $180 | $6.93 | n/a | 11 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20.41 | $2.15 | n/a | 23 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $80 | $0.5177 | n/a | 18 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $15 | $0.000001 | n/a | 14 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $250.69 | n/a | 1 | Sep 8, 2015 |
Revolution Medicines
Oct 19, 2026
Reiterated: Buy
Price Target: $240 → $241
Current: $186.99
Upside: +28.88%
Perspective Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $11
Current: $1.61
Upside: +583.23%
Nurix Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $34 → $33
Current: $25.34
Upside: +30.23%
Genmab
Oct 8, 2026
Reiterated: Buy
Price Target: $45
Current: $43.79
Upside: +2.76%
MannKind
Oct 8, 2026
Reiterated: Buy
Price Target: $6 → $5
Current: $3.19
Upside: +56.74%
BeOne Medicines AG
Oct 8, 2026
Reiterated: Buy
Price Target: $420
Current: $377.63
Upside: +11.22%
Agios Pharmaceuticals
Oct 7, 2026
Reiterated: Buy
Price Target: $37
Current: $37.00
Upside: -
Amgen
Oct 7, 2026
Reiterated: Hold
Price Target: $380
Current: $439.26
Upside: -13.49%
Exelixis
Oct 7, 2026
Reiterated: Hold
Price Target: $54
Current: $64.53
Upside: -16.32%
Gilead Sciences
Oct 7, 2026
Reiterated: Buy
Price Target: $158
Current: $156.04
Upside: +1.26%
Oct 7, 2026
Reiterated: Buy
Price Target: $286
Current: $214.00
Upside: +33.64%
Oct 7, 2026
Reiterated: Buy
Price Target: $772 → $780
Current: $805.02
Upside: -3.11%
Oct 7, 2026
Reiterated: Buy
Price Target: $87 → $85
Current: $24.40
Upside: +248.36%
Oct 7, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $28.22
Upside: +20.48%
Sep 28, 2026
Reiterated: Buy
Price Target: $29
Current: $25.18
Upside: +15.17%
Sep 22, 2026
Reiterated: Buy
Price Target: $155 → $151
Current: $88.01
Upside: +71.57%
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.57
Upside: -
Sep 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $61.71
Upside: -
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.71
Upside: -
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.37
Upside: -
Aug 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.44
Upside: -
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.68
Upside: -
Jul 31, 2026
Reiterated: Hold
Price Target: $7
Current: $3.55
Upside: +97.18%
May 19, 2025
Reiterated: Buy
Price Target: $26
Current: $19.73
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $8
Current: $1.44
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $5
Current: $0.8971
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $20
Current: $3.53
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $16
Current: $10.04
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: $48 → $46
Current: $0.51
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $26
Current: $36.42
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $16
Current: $0.1651
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $12 → $13
Current: $7.85
Upside: n/a
May 6, 2025
Reiterated: Hold
Price Target: $38
Current: $45.15
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: $2,160 → $180
Current: $6.93
Upside: n/a
May 15, 2023
Reiterated: Hold
Price Target: $20.41
Current: $2.15
Upside: n/a
Mar 16, 2022
Reiterated: Hold
Price Target: $5 → $80
Current: $0.5177
Upside: n/a
Nov 12, 2021
Reiterated: Hold
Price Target: $1 → $15
Current: $0.000001
Upside: n/a
Sep 8, 2015
Rated: Buy
Price Target: $348
Current: $250.69
Upside: n/a